Provider review
Paid partnerDirect Meds now charges more per month for a single sermorelin supply than for its 90-day plan. It has also pulled its named pharmacy partners from public view, and its BBB reviews average 1.12 out of 5.
Disclosure score, 6 checks
Best forsermorelin from a provider worth reading the FDA warning letter and BBB record for before subscribing
What Direct Meds states on its own site about leaving, getting money back, and what delivery costs. Read on September 2026.
Whether Direct Meds charges to belong, on top of what it charges for the medication. Read on September 2026.
Whether Direct Meds identifies the clinician or medical practice behind the prescription, or describes them only as a group. Read on September 2026.
Direct Meds is a paid partner; this link may earn a commission. Full disclosure.
Sermorelin is the peptide line, sold as an injection. You can buy a 30-day supply or a 90-day plan.
The two terms no longer carry the same monthly figure. The 90-day plan is the cheaper one per month and includes shipping; the single 30-day supply is dearer and adds a shipping charge on top. Staying flexible now costs you more.
This is a change. Through the summer both terms carried one identical monthly rate, which made the cost predictable whichever you chose. A figure you remember from an earlier visit will be wrong in both directions at once.
Both rates are printed on the same card, which is worth something. You can see the trade-off before checkout rather than inside it.
The sermorelin marketing page carries no sermorelin price. The only figures on it sit in a question about the GLP-1 line and belong to sublingual semaglutide and to injections on that line, not to this peptide.
The rates appear one click further in, on the shop page reached through the Add To Cart control on the anti-aging category page. The page named after the product will not tell you what it costs.
Read the shop card rather than the marketing page, and check which figure belongs to which supply before you enter a card.
Direct Meds received an FDA warning letter in September 2025 over how it marketed compounded GLP-1 drugs as equivalent to the FDA-approved products.
The letter concerns marketing and labeling claims, which is how the large majority of warning letters read. It is not a finding about the contents of a vial, and it is not evidence that any medication was contaminated or ineffective.
It also does not concern the sermorelin line covered here. It is disclosed because you should know it exists and be able to read it, not because it settles whether to order.
Direct Meds still offers both injectable and sublingual formats on the GLP-1 line named in that letter, and discloses them alongside it.
Direct Meds once named its 503A pharmacy partners publicly. As of a July 2026 check, those names had been removed in favor of generic licensed-compounding-pharmacy wording.
A disclosure that gets narrower over time deserves more attention than one that was never made. The information existed, and the company chose to stop publishing it.
The site does display a LegitScript certification seal, which is a listing signal rather than a substitute for naming the facility.
BBB customer reviews average 1.12 out of 5 across 226 reviews. Many of those accounts describe unexpected multi-month charges.
That is the sharpest signal on this page, and it points at billing rather than at product. Read the subscription and cancellation terms closely before you enter a card.
Direct Meds is not available in Mississippi, Louisiana or California. It does not publish its full state list, so anyone elsewhere should confirm coverage during intake.
Direct Meds received an FDA warning letter issued September 2025. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.
Direct Meds is set head to head against bmiMD on what each one publishes.
Auren Rx names both its prescribing group, Wasef Health, and its dispensing pharmacy, VialsRX in Houston, with street addresses and phone numbers, and lets a subscriber pause an auto-refill plan on NAD+, sermorelin, glutathione or GHK-Cu instead of forcing a full cancellation.
Auren Rx is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Auren RxIt was issued in September 2025 over how Direct Meds marketed compounded GLP-1 drugs, presenting them as equivalent to the FDA-approved products. It addresses marketing and labeling claims. It is not a finding about what is in a vial, and it does not concern the sermorelin line.
That is your call, and it should be an informed one. A warning letter tells you how a company promoted a product, not whether the medication was contaminated or ineffective. Read the letter, then weigh it against the billing complaints, which are the more concrete concern here.
Yes, and it did not used to. The 90-day plan now carries a lower monthly figure than a single 30-day supply, and it includes shipping the shorter term charges for. Read both figures off the shop card rather than assuming they match.
Direct Meds no longer says. It once named its 503A pharmacy partners publicly, and by a July 2026 check those names had been replaced with generic wording. Ask for the facility name during intake if it matters to you.
No. Mississippi, Louisiana and California are excluded. The company does not publish a full list of the states it does serve, so confirm your own eligibility before paying.
Direct Meds is a paid partner; this link may earn a commission. Full disclosure.